Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalTimes Interest Earned

Kiora Pharmaceuticals (KPRX) Assets Average (2016 - 2025)

Kiora Pharmaceuticals' Assets Average history spans 11 years, with the latest figure at $27.1 million for Q4 2025.

  • For Q4 2025, Assets Average fell 27.84% year-over-year to $27.1 million; the TTM value through Dec 2025 reached $27.1 million, down 27.84%, while the annual FY2025 figure was $30.4 million, 21.0% up from the prior year.
  • Assets Average reached $27.1 million in Q4 2025 per KPRX's latest filing, down from $30.9 million in the prior quarter.
  • In the past five years, Assets Average ranged from a high of $41.6 million in Q2 2024 to a low of $14.8 million in Q4 2023.
  • Average Assets Average over 5 years is $25.0 million, with a median of $21.9 million recorded in 2021.
  • Peak YoY movement for Assets Average: soared 153.29% in 2024, then dropped 27.84% in 2025.
  • A 5-year view of Assets Average shows it stood at $22.8 million in 2021, then decreased by 27.39% to $16.6 million in 2022, then decreased by 10.62% to $14.8 million in 2023, then skyrocketed by 153.29% to $37.5 million in 2024, then fell by 27.84% to $27.1 million in 2025.
  • Per Business Quant, the three most recent readings for KPRX's Assets Average are $27.1 million (Q4 2025), $30.9 million (Q3 2025), and $33.0 million (Q2 2025).